Newer Drugs Beat Gleevec in Head-to-Head Trials
SATURDAY, June 5 (HealthDay News) -- Two new drugs, dasatinib
(Sprycel) and nilotinib (Tasigna), appear better than imatinib
(Gleevec) in treating patients with newly diagnosed chronic myeloid
leukemia and should be considered as first-line treatments, two new
Novel Drug Combats Advanced Melanoma
SATURDAY, June 5 (HealthDay News) -- Scientists say that a new
drug to treat melanoma, the first in its class, improved survival
by 68 percent in patients whose disease had spread from the skin to
other parts of the body.
Targeted Therapy Shows Promise Against Deadly Brain Cancer
SATURDAY, June 5 (HealthDay News) -- A preliminary study has
found that a targeted treatment for medulloblastoma -- the most
common malignant brain cancer in children -- may one day be able to
treat drug-resistant forms of the disease.